Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2019 Filed Nov 13, 2019 22:43 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 472,527 | $7.15 | $3,378,568.05 |
DisclosureSEC source: 0001077183-19-000208 · wf-form4_157368500878449.xml · nonDerivative · entry 4 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,483,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:47 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 4,000 | $22.80 | $91,200.00 |
DisclosureSEC source: 0001077183-19-000188 · wf-form4_157324961050581.xml · nonDerivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,831 Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:47 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 55,556 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-19-000188 · wf-form4_157324961050581.xml · derivative · entry 4 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,444 Underlying: Common Stock · 55,556 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:47 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 51,556 | $22.82 | $1,176,507.92 |
DisclosureSEC source: 0001077183-19-000188 · wf-form4_157324961050581.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,831 Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 21:47 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionCommon Stock | 55,556 | $7.15 | $397,225.40 |
DisclosureSEC source: 0001077183-19-000188 · wf-form4_157324961050581.xml · nonDerivative · entry 1 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:07 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 35,801 | $22.74 | $814,114.74 |
DisclosureSEC source: 0001077183-19-000183 · wf-form4_157290881586746.xml · nonDerivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,640 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · derivative · entry 8 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,666 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · derivative · entry 7 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 6,666 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · derivative · entry 6 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,667 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · derivative · entry 5 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,667 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionCommon Stock | 3,017 | $11.60 | $34,997.20 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · nonDerivative · entry 4 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionCommon Stock | 6,666 | $7.27 | $48,461.82 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · nonDerivative · entry 3 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionCommon Stock | 8,333 | $9.11 | $75,913.63 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · nonDerivative · entry 2 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:15 UTC |
Johnson Kevin CDirector
|
Exercise / conversionCommon Stock | 6,667 | $4.78 | $31,868.26 |
DisclosureSEC source: 0001077183-19-000185 · wf-form4_157290932682472.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:07 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 96,166 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-19-000183 · wf-form4_157290881586746.xml · derivative · entry 4 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,334 Underlying: Common Stock · 96,166 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:07 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 70,473 | $23.11 | $1,628,631.03 |
DisclosureSEC source: 0001077183-19-000183 · wf-form4_157290881586746.xml · nonDerivative · entry 2 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,441 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 23:07 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 96,166 | $8.03 | $772,212.98 |
DisclosureSEC source: 0001077183-19-000183 · wf-form4_157290881586746.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 00:32 UTC |
JONES STEVEN CDirector
|
GiftCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 43,057 Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 00:32 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 1,200 | $21.47 | $25,764.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 46,457 Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 00:32 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 3 | $25.00 | $75.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,676,230 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 00:00 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,333 | $9.11 Strike: $9.11 | $75,913.63 |
DisclosureSEC source: 0001077183-19-000168 · wf-form4_156824638474713.xml · derivative · entry 4 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On July 28, 2016, Alison Hannah was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 00:00 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $6.66 Strike: $6.66 | $22,197.78 |
DisclosureSEC source: 0001077183-19-000168 · wf-form4_156824638474713.xml · derivative · entry 3 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2020-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 15, 2015 Alison Hannah was granted 10,000 stock options, the options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 00:00 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionCommon Stock | 8,333 | $9.11 | $75,913.63 |
DisclosureSEC source: 0001077183-19-000168 · wf-form4_156824638474713.xml · nonDerivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 00:00 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionCommon Stock | 3,333 | $6.66 | $22,197.78 |
DisclosureSEC source: 0001077183-19-000168 · wf-form4_156824638474713.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 11, 2019 00:32 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 1,691 | $25.00 | $42,275.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,676,233 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 21:10 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 1,200 | $25.00 | $30,000.00 |
DisclosureSEC source: 0001077183-19-000158 · wf-form4_156719943258551.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,677,924 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 21:25 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000164 · wf-form4_156754589955907.xml · nonDerivative · entry 5 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,016,589 F2 · kind: Mr. VanOort transferred these shares as a bona fide gift pursuant to a transaction exempt from Section 16(b) under Rule 16b-5. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · derivative · entry 3 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,763 Underlying: Common Stock · 72,763 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC |
Bonello WilliamChief Strategy Officer
|
SaleCommon Stock | 17,000 | $24.83 | $422,110.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:15 UTC |
Bonello WilliamChief Strategy Officer
|
Exercise / conversionCommon Stock | 17,000 | $7.52 | $127,840.00 |
DisclosureSEC source: 0001077183-19-000161 · wf-form4_156719970186232.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:10 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 39,537 | $25.02 | $989,215.74 |
DisclosureSEC source: 0001077183-19-000158 · wf-form4_156719943258551.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,679,124 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 28, 2019 Filed Sep 3, 2019 21:25 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000164 · wf-form4_156754589955907.xml · nonDerivative · entry 4 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial Account for Child Disclosed balance after: 10,000 F3 · kind: Bona fide gift to an account held by Mr. VanOort's child for which Mr. VanOort is the custodian. Read SEC document |
| August 28, 2019 Filed Sep 3, 2019 21:25 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000164 · wf-form4_156754589955907.xml · nonDerivative · entry 3 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,589 F3 · kind: Bona fide gift to an account held by Mr. VanOort's child for which Mr. VanOort is the custodian. Read SEC document |
| August 28, 2019 Filed Sep 3, 2019 21:25 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000164 · wf-form4_156754589955907.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,036,589 F2 · kind: Mr. VanOort transferred these shares as a bona fide gift pursuant to a transaction exempt from Section 16(b) under Rule 16b-5. Read SEC document |
| August 27, 2019 Filed Aug 27, 2019 21:40 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 30,280 | $24.95 | $755,486.00 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,718,661 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
SaleCommon Stock | 15,424 | $24.79 | $382,360.96 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 5 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,102 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:40 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 143,603 | $24.87 | $3,571,406.61 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,748,941 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:41 UTC |
Johnson Kevin CDirector
|
SaleCommon Stock | 11,800 | $24.74 | $291,932.00 |
DisclosureSEC source: 0001077183-19-000154 · wf-form4_156694208760387.xml · nonDerivative · entry 2 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,285 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 8 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 7 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 6,667 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,777 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 6 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,777 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
SaleCommon Stock | 600 | $25.02 | $15,012.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,526 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 2,777 | $9.11 | $25,298.47 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 3 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 3,333 | $7.27 | $24,230.91 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC |
HIPP RAYMOND RDirector
|
Exercise / conversionCommon Stock | 3,017 | $11.60 | $34,997.20 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:40 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 7,456 | $25.72 | $191,768.32 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,892,544 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:41 UTC |
Johnson Kevin CDirector
|
SaleCommon Stock | 41,200 | $25.60 | $1,054,720.00 |
DisclosureSEC source: 0001077183-19-000154 · wf-form4_156694208760387.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,085 Read SEC document |
| August 01, 2019 Filed Nov 13, 2019 22:43 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 6,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000208 · wf-form4_157368500878449.xml · nonDerivative · entry 3 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,010,499 F2 · shares: Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2019 vesting of restricted stock F3 · balance_after: Total reflects transactions which occurred on August 28 and 29, 2019 and reported on Form 4 on September 3, 2019. Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:19 UTC |
TETRAULT LYNN A.Director
|
GrantStock Options (Right to Buy) · Derivative | 4,269 | $0.00 Strike: $22.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000112 · wf-form4_156021597883749.xml · derivative · entry 5 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,269 Underlying: Common Stock · 4,269 shares Expires 2026-06-06 Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:19 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 3,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000112 · wf-form4_156021597883749.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,653 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.